|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 436 for Tnfsf11

Category restricted to Publication (x)

0.035s

Categories

Category: Publication
Type Details Score
Publication
First Author: Hao Y
Year: 2016
Journal: Cardiovasc Res
Title: Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene.
Volume: 110
Issue: 1
Pages: 62-72
Publication
First Author: Liang QQ
Year: 2011
Journal: Bone
Title: The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice.
Volume: 48
Issue: 6
Pages: 1362-9
Publication
First Author: Nishida D
Year: 2021
Journal: Sci Rep
Title: RANKL/OPG ratio regulates odontoclastogenesis in damaged dental pulp.
Volume: 11
Issue: 1
Pages: 4575
Publication  
First Author: Kao SY
Year: 2013
Journal: Neurobiol Dis
Title: Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss.
Volume: 56
Pages: 25-33
Publication
First Author: Xie H
Year: 2011
Journal: Cardiovasc Res
Title: Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.
Volume: 92
Issue: 2
Pages: 296-306
Publication  
First Author: Jansen IDC
Year: 2020
Journal: Int J Mol Sci
Title: LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro.
Volume: 21
Issue: 17
Publication
First Author: Chen Y
Year: 2008
Journal: J Biol Chem
Title: Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis.
Volume: 283
Issue: 43
Pages: 29593-601
Publication
First Author: Knoop KA
Year: 2009
Journal: J Immunol
Title: RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium.
Volume: 183
Issue: 9
Pages: 5738-47
Publication
First Author: Castaneda B
Year: 2011
Journal: J Cell Physiol
Title: Bone resorption control of tooth eruption and root morphogenesis: Involvement of the receptor activator of NF-κB (RANK).
Volume: 226
Issue: 1
Pages: 74-85
Publication
First Author: Streicher C
Year: 2017
Journal: Sci Rep
Title: Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells.
Volume: 7
Issue: 1
Pages: 6460
Publication
First Author: Sun P
Year: 2020
Journal: Biochem Biophys Res Commun
Title: Endogenous parathyroid hormone (PTH) signals through osteoblasts via RANKL during fracture healing to affect osteoclasts.
Volume: 525
Issue: 4
Pages: 850-856
Publication
First Author: Castaneda B
Year: 2013
Journal: PLoS One
Title: Role of RANKL (TNFSF11)-dependent osteopetrosis in the dental phenotype of Msx2 null mutant mice.
Volume: 8
Issue: 11
Pages: e80054
Publication
First Author: Ohno T
Year: 2020
Journal: Biochem Biophys Res Commun
Title: TSLP is a negative regulator of RANKL-induced osteoclastogenesis.
Volume: 530
Issue: 3
Pages: 508-512
Publication
First Author: Szwarc MM
Year: 2015
Journal: PLoS One
Title: Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.
Volume: 10
Issue: 6
Pages: e0128467
Publication
First Author: Won HY
Year: 2011
Journal: PLoS One
Title: Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ mice.
Volume: 6
Issue: 3
Pages: e18168
Publication
First Author: Kapur RP
Year: 2004
Journal: J Bone Miner Res
Title: Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.
Volume: 19
Issue: 10
Pages: 1689-97
Publication
First Author: Hikita A
Year: 2006
Journal: J Biol Chem
Title: Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand.
Volume: 281
Issue: 48
Pages: 36846-55
Publication
First Author: Dimitrova P
Year: 2012
Journal: Arthritis Res Ther
Title: Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis.
Volume: 14
Issue: 4
Pages: R173
Publication
First Author: Piemontese M
Year: 2016
Journal: Am J Physiol Endocrinol Metab
Title: Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
Volume: 311
Issue: 3
Pages: E587-93
Publication
First Author: Takegahara N
Year: 2016
Journal: J Biol Chem
Title: Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts.
Volume: 291
Issue: 7
Pages: 3439-54
Publication
First Author: Xia WF
Year: 2013
Journal: J Cell Biol
Title: Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling.
Volume: 200
Issue: 6
Pages: 821-37
Publication
First Author: Kostenuik PJ
Year: 2009
Journal: J Bone Miner Res
Title: Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.
Volume: 24
Issue: 2
Pages: 182-95
Publication
First Author: Ma J
Year: 2021
Journal: Cell Prolif
Title: The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Volume: 54
Issue: 1
Pages: e12955
Publication
First Author: Kim HJ
Year: 2002
Journal: J Biol Chem
Title: Osteoprotegerin ligand induces beta-casein gene expression through the transcription factor CCAAT/enhancer-binding protein beta.
Volume: 277
Issue: 7
Pages: 5339-44
Publication
First Author: Takayanagi H
Year: 2000
Journal: Nature
Title: T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
Volume: 408
Issue: 6812
Pages: 600-5
Publication
First Author: Nakamura M
Year: 2003
Journal: Endocrinology
Title: Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Volume: 144
Issue: 12
Pages: 5441-9
Publication
First Author: Okahashi N
Year: 2004
Journal: Infect Immun
Title: Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway.
Volume: 72
Issue: 3
Pages: 1706-14
Publication
First Author: Kanazawa K
Year: 2005
Journal: J Bone Miner Res
Title: Self-assembled RANK induces osteoclastogenesis ligand-independently.
Volume: 20
Issue: 11
Pages: 2053-60
Publication
First Author: Fretz JA
Year: 2008
Journal: Mol Endocrinol
Title: Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
Volume: 22
Issue: 3
Pages: 737-50
Publication
First Author: Kim K
Year: 2007
Journal: Blood
Title: MafB negatively regulates RANKL-mediated osteoclast differentiation.
Volume: 109
Issue: 8
Pages: 3253-9
Publication
First Author: Totsuka T
Year: 2009
Journal: J Immunol
Title: RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
Volume: 182
Issue: 10
Pages: 6079-87
Publication
First Author: Song I
Year: 2009
Journal: FEBS Lett
Title: Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
Volume: 583
Issue: 14
Pages: 2435-40
Publication
First Author: Hakozaki A
Year: 2010
Journal: J Immunol
Title: Receptor activator of NF-kappaB (RANK) ligand induces ectodomain shedding of RANK in murine RAW264.7 macrophages.
Volume: 184
Issue: 5
Pages: 2442-8
Publication
First Author: Tan W
Year: 2011
Journal: Nature
Title: Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.
Volume: 470
Issue: 7335
Pages: 548-53
Publication
First Author: Duheron V
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.
Volume: 108
Issue: 13
Pages: 5342-7
Publication
First Author: Chen Z
Year: 2011
Journal: PLoS One
Title: The critical role of IL-34 in osteoclastogenesis.
Volume: 6
Issue: 4
Pages: e18689
Publication
First Author: Furuya Y
Year: 2011
Journal: J Biol Chem
Title: Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts.
Volume: 286
Issue: 42
Pages: 37023-31
Publication
First Author: Kim J
Year: 2010
Journal: Circ Res
Title: Receptor activator of nuclear factor kappaB ligand is a novel inducer of tissue factor in macrophages.
Volume: 107
Issue: 7
Pages: 871-6
Publication
First Author: Hess E
Year: 2012
Journal: J Immunol
Title: RANKL induces organized lymph node growth by stromal cell proliferation.
Volume: 188
Issue: 3
Pages: 1245-54
Publication
First Author: Li C
Year: 2012
Journal: Biochem Biophys Res Commun
Title: RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis.
Volume: 429
Issue: 3-4
Pages: 156-62
Publication
First Author: Rana T
Year: 2012
Journal: Free Radic Biol Med
Title: Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL.
Volume: 53
Issue: 12
Pages: 2298-307
Publication  
First Author: Steinmetz M
Year: 2013
Journal: J Mol Cell Cardiol
Title: Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization.
Volume: 57
Pages: 32-42
Publication
First Author: Li X
Year: 2012
Journal: Genes Cells
Title: Role of intercellular adhesion molecule-2 in osteoclastogenesis.
Volume: 17
Issue: 7
Pages: 568-75
Publication
First Author: Li M
Year: 2016
Journal: J Biol Chem
Title: Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis.
Volume: 291
Issue: 46
Pages: 24160-24171
Publication
First Author: Moriishi T
Year: 2012
Journal: PLoS One
Title: Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Volume: 7
Issue: 6
Pages: e40143
Publication
First Author: Baek JM
Year: 2019
Journal: Biochem Biophys Res Commun
Title: Role of ANTXR1 in the regulation of RANKL-induced osteoclast differentiation and function.
Volume: 510
Issue: 2
Pages: 296-302
Publication
First Author: Li JY
Year: 2019
Journal: J Bone Miner Res
Title: IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.
Volume: 34
Issue: 2
Pages: 349-360
Publication
First Author: Mukherjee A
Year: 2010
Journal: FASEB J
Title: Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.
Volume: 24
Issue: 11
Pages: 4408-19
Publication
First Author: Meijome TE
Year: 2015
Journal: J Cell Physiol
Title: GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice.
Volume: 230
Issue: 4
Pages: 783-90
Publication
First Author: Gutierrez H
Year: 2013
Journal: Open Biol
Title: Regulation of neurite growth by tumour necrosis superfamily member RANKL.
Volume: 3
Issue: 1
Pages: 120150
Publication        
First Author: MGD Nomenclature Committee
Year: 1995
Title: Nomenclature Committee Use
Publication
First Author: Nelson CA
Year: 2012
Journal: Structure
Title: RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.
Volume: 20
Issue: 11
Pages: 1971-82
Publication
First Author: Mahoney DJ
Year: 2008
Journal: J Biol Chem
Title: TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.
Volume: 283
Issue: 38
Pages: 25952-62
Publication
First Author: Wong BR
Year: 1997
Journal: J Biol Chem
Title: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.
Volume: 272
Issue: 40
Pages: 25190-4
Publication
First Author: Miyamoto K
Year: 2011
Journal: J Exp Med
Title: Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization.
Volume: 208
Issue: 11
Pages: 2175-81
Publication
First Author: Desanti GE
Year: 2012
Journal: J Immunol
Title: Developmentally regulated availability of RANKL and CD40 ligand reveals distinct mechanisms of fetal and adult cross-talk in the thymus medulla.
Volume: 189
Issue: 12
Pages: 5519-26
Publication
First Author: Koga T
Year: 2004
Journal: Nature
Title: Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
Volume: 428
Issue: 6984
Pages: 758-63
Publication
First Author: Arai A
Year: 2012
Journal: J Cell Sci
Title: Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
Volume: 125
Issue: Pt 12
Pages: 2910-7
Publication
First Author: Sasaki H
Year: 2009
Journal: Free Radic Biol Med
Title: Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.
Volume: 47
Issue: 2
Pages: 189-99
Publication  
First Author: Tudpor K
Year: 2015
Journal: Bone
Title: Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
Volume: 72
Pages: 14-22
Publication
First Author: Bando JK
Year: 2018
Journal: Immunity
Title: The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells.
Volume: 48
Issue: 6
Pages: 1208-1219.e4
Publication
First Author: Wood MB
Year: 2016
Journal: Am J Physiol Cell Physiol
Title: TNF-α augments RANKL-dependent intestinal M cell differentiation in enteroid cultures.
Volume: 311
Issue: 3
Pages: C498-507
Publication
First Author: Maruyama K
Year: 2006
Journal: J Immunol
Title: Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice.
Volume: 177
Issue: 6
Pages: 3799-805
Publication
First Author: Kong YY
Year: 1999
Journal: Nature
Title: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Volume: 402
Issue: 6759
Pages: 304-9
Publication  
First Author: Conaway HH
Year: 2016
Journal: Bone
Title: Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Volume: 93
Pages: 43-54
Publication
First Author: Li S
Year: 2020
Journal: Cell Death Dis
Title: PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling.
Volume: 11
Issue: 9
Pages: 762
Publication
First Author: Rao S
Year: 2017
Journal: Genes Dev
Title: RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.
Volume: 31
Issue: 20
Pages: 2099-2112
Publication
First Author: Yang YM
Year: 2009
Journal: J Bone Miner Res
Title: Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.
Volume: 24
Issue: 10
Pages: 1763-9
Publication  
First Author: Kamiya N
Year: 2016
Journal: Bone
Title: Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Volume: 91
Pages: 53-63
Publication
First Author: Klauzinska M
Year: 2015
Journal: Am J Pathol
Title: Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
Volume: 185
Issue: 11
Pages: 2907-22
Publication
First Author: Enomoto H
Year: 2003
Journal: J Biol Chem
Title: Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.
Volume: 278
Issue: 26
Pages: 23971-7
Publication  
First Author: Lin J
Year: 2016
Journal: Nat Commun
Title: Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus.
Volume: 7
Pages: 10562
Publication
First Author: Matsuo FS
Year: 2020
Journal: Am J Physiol Endocrinol Metab
Title: RANKL induces beige adipocyte differentiation in preadipocytes.
Volume: 318
Issue: 6
Pages: E866-E877
Publication
First Author: Hada N
Year: 2012
Journal: Bone
Title: Receptor activator of NF-κB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein.
Volume: 50
Issue: 1
Pages: 226-36
Publication
First Author: Shimamura M
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.
Volume: 111
Issue: 22
Pages: 8191-6
Publication
First Author: Bumdelger B
Year: 2016
Journal: PLoS One
Title: Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms.
Volume: 11
Issue: 1
Pages: e0147088
Publication
First Author: Cheung WY
Year: 2016
Journal: J Bone Miner Res
Title: Pannexin-1 and P2X7-Receptor Are Required for Apoptotic Osteocytes in Fatigued Bone to Trigger RANKL Production in Neighboring Bystander Osteocytes.
Volume: 31
Issue: 4
Pages: 890-9
Publication  
First Author: Khalid AB
Year: 2018
Journal: Bone
Title: GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
Volume: 116
Pages: 78-86
Publication
First Author: Nagashima K
Year: 2017
Journal: Nat Immunol
Title: Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota.
Volume: 18
Issue: 6
Pages: 675-682
Publication
First Author: Guerrini MM
Year: 2015
Journal: Immunity
Title: Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Volume: 43
Issue: 6
Pages: 1174-85
Publication
First Author: Bruno RD
Year: 2014
Journal: J Cell Sci
Title: Paracrine-rescued lobulogenesis in chimeric outgrowths comprising progesterone-receptor-null mammary epithelium and redirected wild-type testicular cells.
Volume: 127
Issue: Pt 1
Pages: 27-32
Publication
First Author: Nagashima K
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Targeted deletion of RANKL in M cell inducer cells by the Col6a1-Cre driver.
Volume: 493
Issue: 1
Pages: 437-443
Publication
First Author: Nakamoto T
Year: 2016
Journal: J Cell Biochem
Title: Mice Deficient in CIZ/NMP4 Develop an Attenuated Form of K/BxN-Serum Induced Arthritis.
Volume: 117
Issue: 4
Pages: 970-7
Publication
First Author: Ni S
Year: 2019
Journal: Nat Commun
Title: Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice.
Volume: 10
Issue: 1
Pages: 5643
Publication
First Author: Ajima R
Year: 2008
Journal: FEBS Lett
Title: Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation.
Volume: 582
Issue: 9
Pages: 1313-8
Publication
First Author: Kikuta J
Year: 2013
Journal: J Clin Invest
Title: Dynamic visualization of RANKL and Th17-mediated osteoclast function.
Volume: 123
Issue: 2
Pages: 866-73
Publication
First Author: Geoffroy V
Year: 2002
Journal: Mol Cell Biol
Title: High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
Volume: 22
Issue: 17
Pages: 6222-33
Publication
First Author: Linares GR
Year: 2012
Journal: J Bone Miner Res
Title: Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation.
Volume: 27
Issue: 7
Pages: 1553-65
Publication
First Author: Ohazama A
Year: 2004
Journal: J Dent Res
Title: Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis.
Volume: 83
Issue: 3
Pages: 241-4
Publication
First Author: Lee SH
Year: 2008
Journal: Biochem Biophys Res Commun
Title: NHE10, an osteoclast-specific member of the Na+/H+ exchanger family, regulates osteoclast differentiation and survival [corrected].
Volume: 369
Issue: 2
Pages: 320-6
Publication
First Author: Serrano EM
Year: 2009
Journal: Biochem Biophys Res Commun
Title: Regulation of vacuolar H(+)-ATPase in microglia by RANKL.
Volume: 389
Issue: 1
Pages: 193-7
Publication
First Author: Geng YM
Year: 2019
Journal: Mol Med Rep
Title: LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells.
Volume: 20
Issue: 5
Pages: 4193-4201
Publication
First Author: Kim K
Year: 2005
Journal: J Biol Chem
Title: Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Volume: 280
Issue: 42
Pages: 35209-16
Publication
First Author: Lamothe B
Year: 2007
Journal: Biochem Biophys Res Commun
Title: TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.
Volume: 359
Issue: 4
Pages: 1044-9
Publication
First Author: Beranger GE
Year: 2008
Journal: J Bone Miner Res
Title: Poly(adp-ribose) polymerase-1 regulates Tracp gene promoter activity during RANKL-induced osteoclastogenesis.
Volume: 23
Issue: 4
Pages: 564-71
Publication
First Author: Khapli SM
Year: 2010
Journal: Biochem Biophys Res Commun
Title: Irreversible inhibition of RANK expression as a possible mechanism for IL-3 inhibition of RANKL-induced osteoclastogenesis.
Volume: 399
Issue: 4
Pages: 688-93
Publication
First Author: Lee JM
Year: 2012
Journal: J Immunol
Title: 5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1.
Volume: 189
Issue: 11
Pages: 5284-92
Publication
First Author: Zhao Y
Year: 2013
Journal: FEBS Lett
Title: Inhibition effect of enteropeptidase on RANKL-RANK signalling by cleavage of RANK.
Volume: 587
Issue: 18
Pages: 2958-64
Publication
First Author: Nakashima Y
Year: 2013
Journal: PLoS One
Title: Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.
Volume: 8
Issue: 9
Pages: e72033
Publication
First Author: Obr AE
Year: 2013
Journal: Mol Endocrinol
Title: Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.
Volume: 27
Issue: 11
Pages: 1808-24